Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins

被引：0

作者：

Nyarko, KA

Freedman, J

Song, YQ

Gentry, PA

Ofosu, FA

机构：

[1] Univ Guelph, Guelph, ON N1G 2W1, Canada

[2] Univ Toronto, Toronto, ON, Canada

[3] McMaster Univ, Hamilton, ON, Canada

来源：

THROMBOSIS AND HAEMOSTASIS | 1999年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2588

引用

页码：817 / 817

页数：1

共 50 条

[31] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis [J].

Lin, C. ;

Aberson, H. L. ;

Von der Thusen, J. ;

Borensztajn, K. ;

Spek, C. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187

[32] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis [J].

Lin, Cong ;

von der Thusen, Jan ;

Daalhuisen, Joost ;

ten Brink, Marieke ;

Crestani, Bruno ;

van der Poll, Tom ;

Borensztajn, Keren ;

Spek, C. Arnold .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) :1346-1356

[33] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer [J].

Fujimoto, Daisuke ;

Hirono, Yasuo ;

Goi, Takanori ;

Katayama, Kanji ;

Yamaguchi, Akio .

ANTICANCER RESEARCH, 2008, 28 (2A) :847-854

[34] Astrocyte Activation by Neuronal Prothrombin via Protease-Activated Receptors (PAR-1) [J].

Lyden, Patrick D. ;

Lamb, Jessica A. ;

Kothari, Shweta ;

Rajput, Padmesh S. ;

Lyden, Patrick .

ANNALS OF NEUROLOGY, 2017, 82 :S39-S39

[35] Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1 [J].

Sharma, Mehul ;

Merkulova, Yulia ;

Raithatha, Sheetal ;

Parkinson, Leigh G. ;

Shen, Yue ;

Cooper, Dawn ;

Granville, David J. .

FEBS JOURNAL, 2016, 283 (09) :1734-1747

[36] Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats [J].

Andrade-Gordon, P ;

Derian, CK ;

Maryanoff, BE ;

Zhang, HC ;

Addo, MF ;

Cheung, WM ;

Damiano, BP ;

D'Andrea, MR ;

Darrow, AL ;

De Garavilla, L ;

Eckardt, AJ ;

Giardino, EC ;

Haertlein, BJ ;

McComsey, DF .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01) :34-42

[37] IN VIVO PROTEASE-ACTIVATED RECEPTOR-1 MEDIATED CORONARY VASOREACTIVITY CORRELATES WITH PAR-1 EXPRESSION DISTRIBUTION IN THE CORONARY VASCULAR WALL [J].

Kasasbeh, E. S. ;

Phillips, S. A. ;

Couhtino, L. ;

Williams, P. ;

Nunnally, A. H. ;

Adcock, J. ;

Wang, L. ;

Hamm, H. E. ;

Cleator, J. H. .

CARDIOLOGY, 2015, 131 :285-285

[38] Expression of protease-activated receptor-1 (PAR-1): A differential marker for metastasis of squamous cell carcinoma of the head and neck (SCCHN) [J].

Zhang, X ;

Hunt, JL ;

Landsittel, DP ;

Shin, DM ;

Chen, ZG .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) :1309S-1309S

[39] The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease [J].

Nilsen, Dennis W. T. ;

Roysland, Michelle ;

Ueland, Thor ;

Aukrust, Pal ;

Michelsen, Annika E. ;

Staines, Harry ;

Barvik, Stale ;

Kontny, Frederic ;

Nordrehaug, Jan Erik ;

Bonarjee, Vernon V. S. .

THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) :510-521

[40] Activation of protease-activated receptor-1 (PAR-1) causes cyclooxygenase (COX) and MAP kinase mediated chloride secretion in an epithelial cell line. [J].

Buresi, MC ;

Buret, A ;

Hollenberg, MD ;

MacNaughton, WK .

FASEB JOURNAL, 2001, 15 (04) :A501-A501

← 1 2 3 4 5 →